These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 37809107)
1. Pulmonary exacerbations in early cystic fibrosis lung disease are marked by strong modulation of CD3 and PD-1 on luminal T cells. Giacalone VD; Giraldo DM; Silva GL; Hosten J; Peng L; Guglani L; Tirouvanziam R Front Immunol; 2023; 14():1194253. PubMed ID: 37809107 [TBL] [Abstract][Full Text] [Related]
8. Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease. Fantino E; Gangell CL; Hartl D; Sly PD; BMC Pulm Med; 2014 Feb; 14():28. PubMed ID: 24576297 [TBL] [Abstract][Full Text] [Related]
9. Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1. Ingersoll SA; Laval J; Forrest OA; Preininger M; Brown MR; Arafat D; Gibson G; Tangpricha V; Tirouvanziam R J Immunol; 2015 Jun; 194(11):5520-8. PubMed ID: 25926674 [TBL] [Abstract][Full Text] [Related]
10. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group. Ratjen F; Rietschel E; Griese M; Ballmann M; Kleinau I; Döring G; Reinhardt D; Paul K Eur Respir J; 2000 Jan; 15(1):141-5. PubMed ID: 10678636 [TBL] [Abstract][Full Text] [Related]
11. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation. Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645 [TBL] [Abstract][Full Text] [Related]
12. Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations. Martin C; Dhôte T; Ladjemi MZ; Andrieu M; Many S; Karunanithy V; Pène F; Da Silva J; Burgel PR; Witko-Sarsat V Front Immunol; 2022; 13():1012310. PubMed ID: 36248793 [TBL] [Abstract][Full Text] [Related]
13. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha. Ratjen F; Paul K; van Koningsbruggen S; Breitenstein S; Rietschel E; Nikolaizik W Pediatr Pulmonol; 2005 Jan; 39(1):1-4. PubMed ID: 15532079 [TBL] [Abstract][Full Text] [Related]
14. Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis. Turnbull AR; Pyle CJ; Patel DF; Jackson PL; Hilliard TN; Regamey N; Tan HL; Brown S; Thursfield R; Short C; Mc Fie M; Alton EWFW; Gaggar A; Blalock JE; Lloyd CM; Bush A; Davies JC; Snelgrove RJ J Cyst Fibros; 2020 Jan; 19(1):40-48. PubMed ID: 31176670 [TBL] [Abstract][Full Text] [Related]
15. Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage. Erdmann N; Schilling T; Hentschel J; Lehmann T; von Bismarck P; Ankermann T; Duckstein F; Baier M; Zagoya C; Mainz JG Front Immunol; 2022; 13():947359. PubMed ID: 36466839 [TBL] [Abstract][Full Text] [Related]
16. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis. Seidl E; Kiermeier H; Liebisch G; Ballmann M; Hesse S; Paul-Buck K; Ratjen F; Rietschel E; Griese M J Cyst Fibros; 2019 Nov; 18(6):790-795. PubMed ID: 31029606 [TBL] [Abstract][Full Text] [Related]
17. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298 [TBL] [Abstract][Full Text] [Related]
19. Nasal wash as an alternative to bronchoalveolar lavage in detecting early pulmonary inflammation in children with cystic fibrosis. Pitrez PM; Brennan S; Turner S; Sly PD Respirology; 2005 Mar; 10(2):177-82. PubMed ID: 15823182 [TBL] [Abstract][Full Text] [Related]
20. Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients. Wojewodka G; De Sanctis JB; Bernier J; Bérubé J; Ahlgren HG; Gruber J; Landry J; Lands LC; Nguyen D; Rousseau S; Benedetti A; Matouk E; Radzioch D PLoS One; 2014; 9(2):e88567. PubMed ID: 24533110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]